Applied Clinical Trials-04-01-2014

Applied Clinical Trials

Examining a region's comparator reimbursement climate to better inform trial expansion decisions.

Applied Clinical Trials
Business News

April 01, 2014

Industry news focusing on the people and organizations who work in the clinical trials profession.

News
Applied Clinical Trials

April 01, 2014

As pair of initiatives show, the clinical trials community in Europe is working harder to get its message across to its key partner: patients.

Applied Clinical Trials
Feature Article

April 01, 2014

The integration of pre-screening all patients for eligibility in oncology studies.

Applied Clinical Trials

When examining the frequency in use of keywords related to cancer research, some important trends emerge.

Applied Clinical Trials
View from Brussels

April 01, 2014

The advent of new drugs for tuberculosis is posing some interesting challenges for regulators in Europe.

Applied Clinical Trials

ISR

News
Applied Clinical Trials

April 01, 2014

Despite guidances and rules advising sponsors to include all demographic groups in clinical trials, many subgroups remain underrepresented.

Applied Clinical Trials

Half of all drugs in clinical testing are interrupted by in-licensing, co-development, joint venture and M&A arrangements – and they are taking significantly more time to develop.

Applied Clinical Trials

The prevalence of cardiovascular toxicity associated with oncology drugs has triggered a new clinical discipline that aims to promote safer drugs and better outcomes for cancer patients.

Applied Clinical Trials

April 01, 2014

S

Issue PDF
Applied Clinical Trials

April 01, 2014

Sites: Making a Difference in Cancer Trials Accrual Trial Design: Oncology Trial Comparator Drug Reimbursement Also in this issue: Singular Approach to Combination Trials Risk Sharing and Interrupted Drug Development Cardio-Oncology: A New Clinical Discipline